Tango Therapeutics, Inc. financial statements
Tango Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 62.38M | 10-K |
| Net income | −USD 101.59M | 10-K |
| Cash and equivalents | USD 112.28M | 10-Q |
| Total debt | USD 33.57M | EODHD |
Tango Therapeutics, Inc. financials on 6ix · Tango Therapeutics, Inc. on 6ix